Amos Adler, President, Memotext
Glaucoma, the world’s second leading cause of blindness, has a number of effective therapies to help those afflicted. Despite these solutions, non-adherence rates for those treatments are reported to be between thirty-seven and fifty-nine percent. Luckily, mobile health professionals are working on ways to solve this issue. One such company, Memotext, has been...
